Genfit S.A. is a biotechnology company focused on developing innovative therapeutic and diagnostic solutions for liver diseases and metabolic disorders

With a strong emphasis on research and clinical development, Genfit's proprietary technologies aim to identify and address various health conditions related to liver dysfunction, including non-alcoholic steatohepatitis (NASH) and other hepatic pathologies. The company is committed to advancing the understanding of these diseases and improving patient outcomes through its drug candidates and diagnostic tools, leveraging both its scientific expertise and strategic partnerships in the healthcare sector.